My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jubilant Life Sciences gains on USFDA nod for generic drug

Jubilant Life Sciences gains on USFDA nod for generic drug

Feb 27,2017

The announcement was made during market hours today, 27 February 2017.

Meanwhile, the S&P BSE Sensex was almost unchanged at 28,893.03.

On the BSE, 63,000 shares were traded on the counter so far as against the average daily volumes of 1.37 lakh shares in the past one quarter. The stock had hit a high of Rs 728 and a low of Rs 704 so far during the day.

The stock had hit a record high of Rs 765 on 7 February 2017 and a 52-week low of Rs 287.20 on 29 February 2016. It had underperformed the market over the past one month till 23 February 2017, gaining 4.7% compared with the Sensexs 6.55% rise. The scrip had also underperformed the market over the past one quarter, advancing 8.83% as against the Sensexs 10.91% rise.

The large-cap company has equity capital of Rs 15.93 crore. Face value per share is Rs 1.

ltraconazole Capsules, 100 mg, is the generic version of Sporanox of Janssen Pharmaceuticals, which is used for the treatment of fungal infections.

Jubilant Life Sciences has received 8 approvals from the United States Food and Drug Administration (USFDA) during the year. As on 31 December 2016, Jubilant Life Sciences had a total of 73 abbreviated new drug application (ANDAs) for oral solids filed in the US, of which 49 have been approved.

On a consolidated basis, Jubilant Life Sciences net profit fell 2.6% to Rs 119.78 crore on 8.7% growth in net sales to Rs 1438.81 crore in Q3 December 2016 over Q3 December 2015.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients and drug discovery solutions. The pharmaceuticals segment, through its wholly owned subsidiary Jubilant Pharma, is engaged in manufacture and supply of APIs, solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile and non-sterile products through 6 USFDA approved manufacturing facilities in India, USA and Canada.

The life science ingredients segment, is engaged in specialty intermediates, nutritional products and life science chemicals through 5 manufacturing facilities in India. The drug discovery solutions segment, provides proprietary in-house innovation & collaborative research and partnership for out-licensing through 3 world class research centres in India and USA.

Powered by Capital Market - Live News

S Chand & Company drops after poor Q1 result
Aug 22,2017

The result was announced after market hours yesterday, 21 August 2017.

Meanwhile, the BSE Sensex was up 74.45 points, or 0.24%, to 31,333.30. The BSE Small-Cap index was down 45.63 points, or 0.29%, to 15,422.24.

On the BSE, 4,369 shares were traded in the counter so far, compared with an average volume of 44,743 shares in the past one quarter. The stock had hit a high of Rs 490 and a low of Rs 474.90 so far during the day. The stock had hit a record high of Rs 707 on 9 May 2017. The stock had hit a record low of Rs 425 on 11 August 2017.

The stock had underperformed the market over the past one month till 21 August 2017, falling 8.62% compared with 2.4% decline in the Sensex. The scrip had also underperformed the market in past one quarter, declining 14.46% as against Sensexs 2.61% rise.

The small-cap company has an equity capital of Rs 17.42 crore. Face value per share is Rs 5.

S Chand and Companys net sales rose 86.11% to Rs 29.35 crore in Q1 June 2017 over Q1 June 2016.

S Chand and Company is a leading Indian education content company. The company delivers content, solutions and services across the education lifecycle through its K-12, higher education and early learning segments.

Powered by Capital Market - Live News

Dr Reddys in pink of health after out-licensing drug
Aug 22,2017

The announcement was made during market hours today, 22 August 2017.

Meanwhile, the S&P BSE Sensex was up 56.97 points or 0.18% at 31,315.82.

On the BSE, 17,189 shares were traded on the counter so far as against the average daily volumes of 52,400 shares in the past one quarter. The stock had hit a high of Rs 1,963 and a low of Rs 1,937.95 so far during the day. The stock had hit a 52-week high of Rs 3,394.95 on 28 October 2016 and a 52-week low of Rs 1,901.65 on 11 August 2017.

The stock had declined 3.82% in two sessions, to settle at Rs 1,933.15 on 21 August 2017, from a close of Rs 2,010 on 17 August 2017.

The stock had underperformed the market over the past one month till 21 August 2017, falling 29.95% compared with 2.4% decline in the Sensex. The scrip had also underperformed the market in past one quarter, declining 27.22% as against Sensexs 2.61% rise. The scrip had also underperformed the market in past one year, dropping 35.8% as against Sensexs 11.33% rise.

The large-cap company has equity capital of Rs 82.91 crore. Face value per share is Rs 5.

Dr Reddys Laboratories through its wholly owned subsidiary Promius Pharma, LLC has out-licensed the future development, manufacturing and commercialization rights of DFD-06, a topical high potency steroid to Encore Dermatology Inc. The drug is intended to be used for treatment of moderate to severe plaque psoriasis.

Under the terms of the agreement, Encore will be responsible for the commercialization of DFD-06 in the United States. Promius Pharma is eligible to receive certain pre and post commercialization milestone payments of upto $32.5 million, followed by fixed royalty payments on net sales.

Anil Namboodiripad, Ph.D, Senior Vice President, Proprietory Products and President, Promius Pharma said that Encore and its management team are well positioned to realize the full potential of this asset DFD-06. The company looks forward to obtaining the new drug application (NDA) approval this fall, enabling Encores management team to quickly deliver this product to the providers and their patients.

Dr Reddys Laboratories consolidated net profit declined 56.6% to Rs 66.60 crore on 2.5% rise in net sales to Rs 3315.90 crore in Q1 June 2017 over Q1 June 2016.

Dr Reddys Laboratories is an integrated global pharmaceutical company.

Powered by Capital Market - Live News

Rain Industries declines after recent sharp rally
Aug 22,2017

Meanwhile, the S&P BSE Sensex was up 83 points, or 0.27% at 31,341.85. The S&P BSE Mid-Cap index was down 17.76 points, or 0.12% at 14,969.75.

On the BSE, 2.81 lakh shares were traded on the counter so far as against the average daily volumes of 3.35 lakh shares in the past one quarter. The stock had hit a high of Rs 142.80 and a low of Rs 132.90 so far during the day. The stock had hit a record high of Rs 147.90 on 21 August 2017 and a 52-week low of Rs 40.20 on 19 August 2016.

The stock had outperformed the market over the past one month till 21 August 2017, advancing 8.41% compared with the Sensexs 2.4% fall. The scrip had also outperformed the market over the past one quarter gaining 35.07% as against the Sensexs 2.61% rise. The scrip had also outperformed the market over the past one year advancing 239.32% as against the Sensexs 11.33% rise.

The mid-cap company has equity capital of Rs 67.27 crore. Face value per share is Rs 2.

Shares Rain Industries had rallied 24.82% in the preceding six trading sessions to settle at Rs 139.80 yesterday, 21 August 2017, from its close of Rs 112 on 10 August 2017.

Rain Industries consolidated net profit rose 12.5% to Rs 151.31 crore on 5.2% increase in net sales to Rs 2637.12 crore in Q2 June 2017 over Q2 June 2016.

Rain Industries is engaged in the business of manufacture and sale of carbon products, chemicals and cement.

Powered by Capital Market - Live News

Fitch: Global Reinsurers 1H17 Results Reflect Pricing Pressure
Aug 22,2017

Global reinsurers 1H17 results provide further evidence of continuing pressure on pricing and earnings, Fitch Ratings says. Intense competition among global reinsurers and the abundance of capital invested in the sector mean pricing will continue to weaken, with low investment yields putting further strain on profitability. The sector outlook remains negative and we expect consolidation as reinsurers have little opportunity for organic growth.

Non-life reinsurance underwriting profits fell in 1H17 due to lower surpluses from prior-year reserves. Most companies were hit by the cut in the Ogden discount rate for UK liability business, which will lead to higher lump-sum payments being calculated for long-term care costs or lost earnings.

But underwriting was still profitable, helped by lower catastrophe-related losses. Worldwide natural catastrophe insured losses were USD19.5 billion, 39% down on 1H16 (USD32 billion) and 33% below the 10-year first-half average (USD29 billion).

Shareholders equity grew by 2.5% in 1H17, with underwriting profits slightly exceeding share repurchases and shareholder dividends. Reinsurance capacity remains ample.

There was record issuance of catastrophe bonds in 1H17, driven by demand from capital market investors attracted to reinsurance risk to diversify their exposure.

The rating outlook for the global reinsurance sector remains stable, driven particularly by very strong capitalisation. But further deterioration in profit metrics could result in negative rating actions.

Powered by Capital Market - Live News

HCL Infosystems gallops after signing agreement with Apple
Aug 22,2017

The announcement was made after market hours yesterday, 21 August 2017.

Meanwhile, the BSE Sensex was up 43.75 points, or 0.14%, to 31,302.60. The BSE Small-Cap index was down 83.96 points, or 0.54%, to 15,383.91.

On the BSE, 11.24 lakh shares were traded in the counter so far, compared with an average volume of 5.04 lakh shares in the past one quarter. The stock had hit a high of Rs 50.50 and a low of Rs 48.10 so far during the day. The stock had hit a 52-week high of Rs 64.85 on 25 January 2017. The stock had hit a 52-week low of Rs 39.20 on 21 November 2016.

The small-cap company has an equity capital of Rs 44.60 crore. Face value per share is Rs 2.

HCL Infosystems announced that the company has yesterday, 21 August 2017 signed a distributor agreement with Apple India for distribution of iPhones and other Apple products.

HCL Infosystems reported consolidated net loss of Rs 55.12 crore in Q1 June 2017, higher than net loss of Rs 35.70 crore in Q1 June 2016. Net sales fell 40.35% to Rs 684.23 crore in Q1 June 2017 over Q1 June 2016.

HCL Infosystems is Indias premier IT services, solutions & distribution company.

Powered by Capital Market - Live News

Ind-Ra: GST Credit Positive for States in Medium to Long Term
Aug 22,2017

India Ratings and Research (Ind-Ra) says the implementation of goods and services tax (GST) will have a positive impact on state governments finances in the medium to long term. Even in the short term, the impact on aggregate state finances will be positive but Ind-Ras calculation shows that the picture varies across states.

Nine state-level taxes included in GST are: state value added tax, central sales tax, purchase tax, luxury tax, entry tax (all forms), entertainment tax (except those levied by local bodies), taxes on advertisements, taxes on lotteries, betting and gambling and state cesses and surcharges insofar as they relate to the supply of goods or services. However, taxes on i) income, ii) property and capital transactions, iii) petroleum products, iv) state excise and v) electricity duty are not part of GST and states would continue to levy and collect these in the same manner as earlier.

At an aggregate level, the state taxes that are subsumed in GST accounted for 55% of states own tax revenue and grew at 14.0% during FY12-FY17. This is exactly the rate at which if state taxes that are subsumed in GST grow in FY18 over FY16, then centre will not be required to compensate states for any revenue loss. However, there are wide variations across states, with subsumed GST taxes growing at just 8.47% for Punjab during FY12-FY17 but 39.70% for Telangana.

Ind-Ras calculation shows that GST revenues of all states combined will grow at a CAGR of 16.6% in FY18 over FY16. However, since the picture at the individual state level differs, eight states namely Andhra Pradesh, Chhattisgarh, Gujarat, Himachal Pradesh, Madhya Pradesh, Odisha, Punjab and Tamil Nadu would need compensation from the central government for any revenue loss under baseline scenario. This would cost INR56 billion to the central government in FY18.

As post introduction of GST, input tax credit is available on both goods and services, Ind-Ras calculation shows that the growth of GST component of states own tax revenue for all states in such a case would drop to 15.5% in FY18 (base line scenario 16.6%) and three more states namely, Goa, Jammu and Kashmir and Jharkhand would require compensation from the central government. The total compensation amount therefore would increase to INR95 billion in FY18 (baseline scenario: INR56 billion). This is based on the assumption that in the final production of goods and services, service tax accounts for 10%.

Like the state VAT which was rolled out from April 2005 to January 2008, implementation of GST will also bring in some efficiency gains. If we combine the 5% efficiency gain with 10% input tax credit on services tax, then only five states namely Chhattisgarh, Gujarat, Odisha, Punjab and Tamil Nadu would need compensation from the central government and the total compensation amount would drop to INR37 billion in FY18.

To be able to absorb the positive impact of GST on state finances, Ind-Ra believes states will have to keep a constant vigil on the buoyancy of taxes that are outside the purview of GST as also their own non-tax revenues.

Powered by Capital Market - Live News

ONGC gets energized after board approves acquisition of HPCL
Aug 22,2017

The announcement was made after market hours yesterday, 21 August 2017.

Meanwhile, the S&P BSE Sensex was down 6.24 points or 0.02% at 31,252.61.

On the BSE, 1.07 lakh shares were traded on the counter so far as against the average daily volumes of 8.84 lakh shares in the past one quarter. The stock had hit a high of Rs 159 and a low of Rs 157.60 so far during the day. The stock had hit a 52-week high of Rs 212 on 31 January 2017 and a 52-week low of Rs 155.30 on 27 June 2017.

The stock had underperformed the market over the past one month till 21 August 2017, falling 4.25% compared with 2.4% decline in the Sensex. The scrip had also underperformed the market in past one quarter, declining 12.47% as against Sensexs 2.61% rise. The scrip had also underperformed the market in past one year, dropping 2.32% as against Sensexs 11.33% rise.

The large-cap company has equity capital of Rs 6416.62 crore. Face value per share is Rs 5.

ONGC said that the companys board of directors considered the proposal for acquisition of 51.11% of share of HPCL from the Government of India and given the in principle approval for the same. Further, the board has constituted a Committee of Directors to examine various aspects of the proposal and to provide its recommendations to the board of directors.

The government of India held 51.11% stake in HPCL as per the shareholding pattern as on 30 June 2017.

Shares of HPCL rose 3.19% to Rs 448.

ONGCs net profit fell 8.2% to Rs 3884.73 crore on 7.2% increase in net sales to Rs 19073.54 crore in Q1 June 2017 over Q1 June 2016.

ONGC is Indias largest oil and gas exploration firm by sales. The Government of India held 68.07% stake in ONGC as per the shareholding pattern as on 30 June 2017.

Powered by Capital Market - Live News

Telecom sector bat for lower financial charges: ASSOCHAM-KPMG study
Aug 22,2017

The financial stress on the telecom sector can be reduced to a great extent by considering a reduction in spectrum usage charges as well as license fees, according to an ASSOCHAM-KPMG joint study.

The high reserve price of spectrum may need to be revisited in light of the financial stress which industry faces in the current scenario. The government may consider uniformity in import duties on Lithium-ion batteries across industries to facilitate affordability of green sites. All associated benefits as part of infrastructure status may be extended to telecom infrastructure companies, reveals the ASSOCHAM-KPMG joint study.

The central government can consider coming up with guidelines to ensure property tax is levied at uniform rates and is consistent across various state and regional authorities. Authorities may consider extending GST benefits to IP-1s (IP-1 Infrastructure Provider) for procurement of telecom towers as well as subsidisation of diesel cost since it forms a part of operational costs for infrastructure providers.

The government may explore the possibility of lowering duty on imports of critical equipment and also evaluate lessening the restrictions imposed on the import of second hand equipment.

Till the time the basic customs duty (BCD) is removed, BCD exemption should be given to OEMs for supply to DTA, which manufacture in SEZ based in India to help keep capex in check.

Skill development programmes may be created with a focus on creating skilled manpower as well as re-skilling of existing manpower in order to be ready for emerging technologies. As per the Indian Telegraph Right of Way rules, IP-1s have not been included under the purview of the same. Inclusion of IP-1s under the same will help increase efficiencies in laying down infrastructure across the country. There is a need for defining a security framework around telecom infrastructure allowing it to be treated as essential infrastructure and stringent penal provisions need to be in place to mitigate risk of damage to these assets.

The industry is of the view that the government may increase the MEIS incentive and introduce new incentives to attract more players in the market and to encourage the existing players to ramp up manufacturing Implementation targets of e-waste collection need to be reviewed, as against the current requirement, to ensure compliance across the industry. ASSOCHAM recommends reconsideration of TEC testing of telecom equipment in favor of an SDoC (Supplier Declaration of Conformity (SDoC) regime.

The government may consider making E and V bands available in order to provide better last mile connectivity to subscribers. In order to reduce the burden on infrastructure providers, industry recommend classification of common telecom/ digital infrastructure under a common umbrella and be allowed to be shared amongst licensed TSPs under existing registration certificates.

Approval process for handsets should be streamlined to ensure competitive advantage does not get lost for handset manufacturers while launching new products. The Preferential Market Access (PMA) policy may be revised to ensure level playing field for local and global telecom equipment manufacturers.

Uniform and seamless implementation of Right of Way Rules 2016, across central, state governments and local municipal bodies will help ease deployment of overground and underground infrastructure and provide a level-playing field for telecom infrastructure provisioning. These recommendations, if considered for implementation would help industry in coping with the financial burden currently faced, helping improve business performance as well as prepare for the next wave of growth in terms of new technologies such as IoT, M2M, 5G etc. and continue in the path of connecting the country and helping the government achieve the digital dream and inclusive development.

Powered by Capital Market - Live News

Lupin rebounds after USFDA clears Aurangabad facility
Aug 22,2017

The announcement was made after market hours yesterday, 21 August 2017.

Meanwhile, the S&P BSE Sensex was up 92.98 points, or 0.3% to 31,366.84.

On the BSE, 49,065 shares were traded in the counter so far, compared with average daily volumes of 2.01 lakh shares in the past one quarter. The stock had hit a high of Rs 950.55 and a low of Rs 936 so far during the day. The stock had hit a 52-week high of Rs 1,599 on 19 August 2016. The stock had hit a 52-week low of Rs 920 yesterday, 21 August 2017.

The stock had declined 4.63% in four sessions to settle at Rs 922.80 on 21 August 2017 from a close of Rs 967.60 on 14 August 2017.

The stock had underperformed the market over the past one month till 21 August 2017, falling 19.25% compared with 2.4% decline in the Sensex. The scrip had also underperformed the market in past one quarter, declining 29.82% as against Sensexs 2.61% rise. The scrip had also underperformed the market in past one year, dropping 41.49% as against Sensexs 11.33% rise.

The large-cap company has equity capital of Rs 90.35 crore. Face value per share is Rs 2.

Lupin announced that it has received notification that the inspection carried out by the United States Food & Drug Administration (USFDA) in April 2017 at its Aurangabad facility is now closed and the agency has issued an Establishment Inspection Report (EIR). This closes all outstanding USFDA inspections at Lupins Aurangabad facility.

Lupins consolidated net profit fell 59.4% to Rs 358.06 crore on 12.3% decline in net sales to Rs 3806.83 crore in Q1 June 2017 over Q1 June 2016.

Lupin is a transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Powered by Capital Market - Live News

McNally Bharat Engineering extends rally after new order win
Aug 22,2017

Meanwhile, the S&P Sensex was up 69.47 points or 0.22% at 31,328.32. The S&P Small-Cap index was up 13.67 points or 0.09% at 15,481.54.

On the BSE, 31,000 shares were traded on the counter so far as against the average daily volumes of 74,076 shares in the past one quarter. The stock had hit a high of Rs 72 and a low of Rs 71 so far during the day. The stock had hit a 52-week high of Rs 79.50 on 31 July 2017 and a 52-week low of Rs 37.60 on 30 May 2017.

The small-cap company has equity capital of Rs 57.39 crore. Face value per share is Rs 10.

Shares of McNally Bharat Engineering Company had gained 4.02% to settle at Rs 68.60 yesterday, 21 August 2017. The announcement of the new order win was made at fag end of the days trading session yesterday, 21 August 2017.

McNally Bharat Engineering Company said that the company has received an order for work of Engineering, Procurement and Construction (EPC) of 8 MTPA capacity Coal Handling Plant (CHP) with allied infrastructural facilities and Operation & Maintenance (O&M) of the CHP for initial two years and Supervision & Handholding for one year at Manoharpur Coal Mine of Odisha Coal and Power (OCPL) in the district of Sundargarh, Odisha.

McNally Bharat Engineering Company reported net loss of Rs 101.89 crore in Q1 June 2017, lower than net loss of Rs 196.98 crore in Q1 June 2016. Net sales fell 3.06% to Rs 379.94 crore in Q1 June 2017 over Q1 June 2016.

McNally Bharat Engineering Company is a engineering company engaged in providing turnkey solutions in the areas of power, steel, aluminum, material handling, mineral beneficiation, pyroprocessing, pneumatic handling of powdered materials including fly ash handling and high concentrate disposal, coal washing, port cranes, cement, oil & gas, civic and industrial water supply etc.

Powered by Capital Market - Live News

Eros Worldwide sells 1.17 crore equity shares of Eros International Media
Aug 22,2017

Eros Worldwide FZ LLC, the promoter of Eros International Media has completed the sale of 1,17,16,850 equity shares of Eros International Media between April to August 2017 amounting to over $40 million to reduce its revolving credit facility. With the paydown from the sale of shares and internal accruals, the $123 million facility now stands reduced to approx. $45 million.

Post this sale and as of date, Eros Worldwide together with Eros Digital continue to own 60.47% of Eros International Media.

Powered by Capital Market - Live News

123Stores ranks #689 in Inc. 5000 list
Aug 22,2017

Intrasoft Technologies announced that 123Stores, Inc., the multi-channel online retailer, had been placed by Inc. magazine on its 36th annual Inc.5000 list, which honors the nations fastest-growing companies.

123Stores was ranked #689 on the 2017 list, as compared to #1641 on the 2014 list and this is the second year that 123Stores has featured in this prestigious list. The 2017 Inc. 5000 is ranked according to percentage revenue growth, between 2013 to 2016.

Powered by Capital Market - Live News

Shares of KIOCL get listed
Aug 22,2017

The equity shares of KIOCL (Scrip Code: 540680) are listed effective 22 August 2017 and admitted to dealings on the Exchange in the list of B Group Securities.

Powered by Capital Market - Live News

Indias Exclusive Rights to Explore Polymetallic Nodules from Central Indian Ocean Seabed Basin Extended by Five Years
Aug 22,2017

Indias exclusive rights to explore polymetallic nodules from seabed in Central Indian Ocean Basin (CIOB) have been extended by five years. These rights are over 75000 sq. km of area in international waters allocated by International Seabed Authority for developmental activities for polymetallic nodules. The estimated polymetallic nodule resource potential is 380 million tonnes, containing 4.7 million tonnes of nickel, 4.29 million tonnes of copper and 0.55 million tonnes of cobalt and 92.59 million tonnes of manganese. This has been approved unanimously in the 23rd session of International Seabed Authority (ISA) concluded on August 18, 2017 at Kingston, Jamaica.

India is the first country to have received the status of a pioneer investor in 1987 and was allocated an exclusive area in Central Indian Ocean Basin by United Nations (UN) for exploration and utilization of nodules. India is one among the top 8-countries/ contractors and is implementing a long-term programme on exploration and utilization of Polymetallic Nodules through Ministry of Earth Sciences. This includes survey and exploration, environmental studies, technology development in mining and extractive metallurgy, in which significant contributions have been made.

While, the extraction of metals from the polymetallic nodules lying at the deep ocean floor is not yet found to be economically viable at this stage, an area of about 7860 square km has been identified in the CIOB for the First Generation Mine Site on the basis of detailed surveys and analysis. Environmental studies for mining of deep-sea polymetallic nodules were also carried out to evaluate the possible impacts of mining on deep-sea environment.

A Remotely Operable Submersible (ROSUB 6000), capable of operating at 6000 m water depth was also developed and tested successfully at a depth of 5289 m. A remotely operable in-situ soil testing equipment was also developed for obtaining detailed geotechnical properties of the mining area at CIOB and tested successfully at 5462 m water depth.

A mining system is under development which has been tested for 500m water depth. Metallurgical process routes for extracting copper, nickel and cobalt from polymetallic nodules have been developed and tested in a demonstration pilot plant set up on semi-continuous basis at Hindustan Zinc Limited, Udaipur with a capacity to process 500 kg nodules per day.

International Seabed Authority (ISA) is a UN body set up to regulate the exploration and exploitation of marine non-living resources of oceans in international waters. India actively contributes to the work of International Seabed Authority. Last year, India was re-elected as a member of Council of ISA. Indias nominees on Legal and Technical Commission and Finance Committee of the ISA were also elected last year.

Powered by Capital Market - Live News

Shares of Ashok Masala Mart get listed
Aug 22,2017

The equity shares of Ashok Masala Mart (Scrip Code: 540681) are listed effective 22 August 2017 and admitted to dealings on the Exchange in the list of M Group Securities.

Powered by Capital Market - Live News